278 filings
Page 5 of 14
8-K
c2jarin
16 Aug 22
BioSig Sees Positive Momentum from Sales Pipeline Growth
9:47am
8-K
srgns
15 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
1fydu9vlxl7 wbhaaozx
7 Jul 22
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
11:32am
8-K
jrbf0uqo9 ksys
30 Jun 22
BioSig Announces Closing of Public Offering of Common Stock
4:05pm
8-K
cilidf0 ejezf4blqc3g
29 Jun 22
BioSig Announces Proposed Public Offering of Common Stock
9:19am
8-K
rg7rql
17 May 22
Entry into a Material Definitive Agreement
4:57pm
8-K
kgvgiqbt5x8aowkxb
11 May 22
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
10:31am
8-K
u5zv3mz7i7i 79sgc217
10 May 22
Regulation FD Disclosure
11:51am
8-K
rjm7xbxdi
2 May 22
Departure of Directors or Certain Officers
4:00pm
8-K
x9yzrjl9d7enoi8cx4
28 Apr 22
Departure of Directors or Certain Officers
11:02am
8-K
j8xa5w1g
29 Mar 22
BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services
2:25pm
8-K
0t7o4 nenr
24 Mar 22
Entry into a Material Definitive Agreement
4:54pm
8-K
i3dnweqbl5ep9
22 Mar 22
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
1:00pm
8-K
n7b5p
26 Jan 22
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
1:56pm
8-K
qszbt
21 Dec 21
BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales
9:00am
8-K
w5303jyt8rspoy 18w
16 Dec 21
Regulation FD Disclosure
9:16am
8-K
0d59f
1 Dec 21
BioSig Technologies, Inc. Appoints Gray Fleming as Chief Commercial Officer
9:25am
8-K
42xf89k9evl lpmj
16 Nov 21
BioSig Initiates Artificial Intelligence Development Program with Technion – Israel Institute of Technology
3:29pm
8-K
9ua1nvzo2lkjjgvg4tx
10 Nov 21
BioSig Adds To Its Clinical Footprint In Texas
9:20am
8-K
xzvdq5v71c3g 2c2
8 Nov 21
Regulation FD Disclosure
11:31am